SEVOFLURANE Price

Overview

Welcome to Dwaey, specifically on SEVOFLURANE Inhalation/Liquid for page.
This medicine contains an important and useful components, as it consists of Sevoflurane.
SEVOFLURANE is available in the market in concentration 0.999 and in the form of Inhalation/Liquid for.

ABBVIE LTD. is the producer of SEVOFLURANE and it is imported from UK, The most popular alternatives of SEVOFLURANE are listed downward .

Mode Of Action

Sevoflurane is a volatile halogenated general anaesthetic which causes a reversible loss of consciousness and pain sensation, suppression of voluntary motor activity, modification of autonomic reflexes, depression of the respiratory and CV systems. It also has muscle relaxant properties.

Indication

• General anaesthesia

Precaution

Patient w/ increased intracranial pressure, neuromuscular disease (esp Duchenne muscular dystrophy), mitochondrial disorders. Patient who are hypovolaemic, hypotensive, haemodynamically compromised, at risk of QT prolongation. Hepatic and renal impairment. Childn. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor for BP, temp, heart rate and rhythm, oxygen saturation, end-tidal CO2, and end-tidal drug concentrations prior to and throughout anaesthesia. Monitor the temp of CO2 absorbent canister. Recovery from general anaesthesia should be assessed carefully before discharge. Lactation: excreted in breast milk; no adverse effect on nursing infant

Side Effects

• Cardiorespiratory depression
• hypotension
• bradycardia; laryngospasm
• increased cough and salivation; urinary retention
• acute renal failure
• changes in liver enzyme values
• liver damage; nausea
• vomiting
• delirium
• seizure; rash
• urticaria
• pruritus
• dyspnoea
• wheezing
• chest discomfort
• bronchospasm
• anaphylactic/anaphylactoid reaction; agitation
• dystonic movements (childn). Potentially Fatal: Malignant hyperthermia. Rarely
• hyperkalaemia resulting in cardiac arrhythmias
• particularly in childn w/ neuromuscular disease.

Contra indication

Known or suspected susceptibility to malignant hyperthermia. Previous hypersensitivity.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.